FDA Webview
X
latest-news

Boston Scientific recalls its ENROUTE Transcarotid Neuroprotection System Plus, a single-use percutaneous catheter kit used during transcarotid artery revascularization.

latest-news

CBER updates its standard operating procedures for resolving scientific/procedural disputes between sponsors and the Center, establishing revised procedures and adding medical devices to the formal dispute resolution process

LATEST NEWS

View All
motusgi
Boston Scientific Recalls ENROUTE Percutaneous Catheter Kit

Boston Scientific recalls its ENROUTE Transcarotid Neuroprotection System Plus, a single-use percutaneous catheter kit used during transcarotid artery revascularization.

motusgi
CBER Updates Process for Formal Disputes With Sponsors

CBER updates its standard operating procedures for resolving scientific/procedural disputes between sponsors and the Center, establishing revised procedures and adding medical devices to the formal dispute resolution process

motusgi
Scholar Rock Removes Catalent Facility from BLA to Advance Apitegromab

Scholar Rock says it has made further regulatory progress for apitegromab, its investigational treatment for spinal muscular atrophy.

motusgi
Lawmakers Urge FDA to Up Scrutiny of Clinical Data From China

House Select Committee on China chairman John Moolenaar (R-MI) and Rep. Ben Cline (R-VA) are urging FDA intensify safeguards on clinical trial data generated in China, citing concerns about transparency and potential underreporting of serious adverse events and patient deaths.

newsletter-first

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Animal Drugs

View All
medical-devices
Read More
Antimicrobial Animal Drug Finalized Safety Guidance

FDA issues a finalized guidance on evaluating the safety of antimicrobial animal drugs based on their role in human medicine.

medical-devices
Read More
Petition Urges FDA to Restrict Antibiotic Use in Animals

A coalition of 65 health, environmental, consumer, farming, and animal welfare organizations petition FDA to withdraw approvals for the routine use of...

medical-devices
Read More
FDA Authorizes 1st Generic Animal Drug for New World Screwworm

FDA authorizes Felix Pharmaceuticals’ generic nitenpyram tablets to treat New World screwworm infestations in dogs and cats.

medical-devices
Read More
Open Letter to Trump Urges FDA Push on Rare Diseases

In an opern letter to president Trump, rare disease advocates urge him to push FDA to accelerate approvals for treatments targeting fatal genetic diso...

Biologics

View All
medical-devices
Read More
CBER Updates Process for Formal Disputes With Sponsors

CBER updates its standard operating procedures for resolving scientific/procedural disputes between sponsors and the Center, establishing revised proc...

medical-devices
Read More
Cellular, Gene Therapy Product FAQs

FDA publishes a guidance with frequently asked questions on the development of cellular and gene therapy products.

medical-devices
Read More
Draft Guidance on Potency Testing for Active Immunotherapy Products

FDA releases a draft guidance that outlines recommendations for developing potency assays for active immunotherapy products, including personalized ca...

medical-devices
Read More
Senators Release 2021 Woodcock Email on Covid-19 Concern

Sens. Ron Johnson (R-WI) and Rand Paul (R-KY) release a 2021 email from then-acting FDA commissioner Janet Woodcock in which she raised concerns about...

FDA General

View All
medical-devices
Read More
Commissioner Pick Faces Potentially Lengthy Senate Confirmation

Senate confirmation of FDA commissioner nominee Heidi Overton appears to be getting some resistance and a quick Senate confirmation seems unlikely.

medical-devices
Read More
Trump Picks Health Policy Adviser Overton as FDA Commissioner Nominee

President Donald Trump selects White House health policy adviser Heidi Overton as his nominee to become FDA commissioner.

medical-devices
Read More
Trump Administration Weighs Executive Order on Autism, Vaccines

The Trump administration considers an executive order addressing vaccines and autism as soon as next week.

medical-devices
Read More
FDA Posts User Fee Rates for FY 2027

FDA posts the following user fee rates for medical product programs for fiscal year 2027.

newsletter-second

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Federal Register

View All
motusgi
Read More
FDA Moves to Cement Complete Response Letter Transparency Policy

FDA looks to formalize one of its most significant transparency initiatives in decades: the public r...

motusgi
Read More
FDA Warns Brazilian Drug Maker Over Records Request

FDA sends a Warning Letter to Brazilian over-the-counter drug manufacturer Aeroflex Industria de Aer...

motusgi
Read More
FDA Delays Review Action on Alzheimer’s Drug

FDA delays by three months its decision on Eisai and Biogen's subcutaneous starting-dose formulation...

motusgi
Read More
Alnylam Pharma’s Web Promo is Misleading: FDA

FDA sends an untitled letter to Alnylam Pharmaceuticals, citing misleading promotional claims on a c...

Human Drugs

View All
motusgi
Read More
Scholar Rock Removes Catalent Facility from BLA to Advance Apitegromab

Scholar Rock says it has made further regulatory progress for apitegromab, its investigational treat...

motusgi
Read More
Lawmakers Urge FDA to Up Scrutiny of Clinical Data From China

House Select Committee on China chairman John Moolenaar (R-MI) and Rep. Ben Cline (R-VA) are urging ...

motusgi
Read More
FDA Issues New Guidance on Therapeutic Equivalence Evaluations

FDA issues a final guidance describing how it evaluates therapeutic equivalence among prescription d...

motusgi
Read More
4 Observations in Suretec Inspection

FDA warns Gilbert, AZ-based Suretec Innovations about CGMP and drug listing violations in its manufa...

Marketing

View All
motusgi
Read More
FDA Plan Would ‘Fundamentally Reshape’ Drug Ads

Two Sheppard attorneys say an FDA proposal to require complete safety and risk information within th...

motusgi
Read More
FDA Cites Sanofi Over Misleading Beyfortus Promotional Emails

FDA sends an untitled letter to Sanofi Vaccines U.S., alleging that promotional emails for its respi...

motusgi
Read More
Friendly Accelerated Approval Disclosures Improve Drug Understanding: Study

A new study suggests that direct-to-consumer prescription drug Web sites may better communicate the ...

motusgi
Read More
DTC Advertising Industry Braces for Potential End of Adequate Provision

DTC Perspectives CEO Bob Ehrlich warns that an upcoming FDA proposal to eliminate the adequate provi...

Medical Devices

View All
motusgi
Read More
Boston Scientific Recalls ENROUTE Percutaneous Catheter Kit

Boston Scientific recalls its ENROUTE Transcarotid Neuroprotection System Plus, a single-use percuta...

motusgi
Read More
Early Alert on : GE HealthCare Portrait Core Monitor Software

CDRH issues an Early Alert after becoming aware that GE HealthCare sent a letter alerting affected c...

motusgi
Read More
Digital Health Technologies Capture Real-Time Info: Column

FDA Digital Health Center of Excellence director Rick Abramson outlines an agency white paper on dev...

motusgi
Read More
Medline Convenience Kit Recall is Class 1

Medline issues a device correction (Class 1 recall) for convenience kits containing B. Braun’s bupiv...